Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Hellmich
The Risk of Tuberculosis Related to Tumour Necrosis Factor Antagonist Therapies: A TBNET Consensus Statement
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Related publications
LTBI: Latent Tuberculosis Infection or Lasting Immune Responses to M. Tuberculosis? A TBNET Consensus Statement
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Pulmonary Granulomas After Tumour Necrosis Factor Alpha Antagonist Therapy
Thorax
Pulmonary
Respiratory Medicine
Reactivation of M. Tuberculosis Infection in Trans-Membrane Tumour Necrosis Factor Mice
PLoS ONE
Multidisciplinary
The Use of the Tumour Necrosis Factor Antagonist Infliximab in Heart Transplant Recipients: Two Case Reports
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
E0154 Expression of Tumour Necrosis Factor- Converting Enzyme and Tumour Necrosis Factor- In Rats With Alcoholic Cardiomyopathy
Heart
Cardiovascular Medicine
Cardiology
Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated With Etanercept – A Tumour Necrosis Factor-Alpha Antagonist
Canadian Journal of Gastroenterology
Crystallization and Preliminary X-Ray Analysis of the Tumour Necrosis Factor Α–tumour Necrosis Factor Receptor Type 2 Complex
Acta Crystallographica Section F Structural Biology and Crystallization Communications
Systemic Cytotoxic and Biological Therapies of Colorectal Liver Metastases: Expert Consensus Statement
HPB
Hepatology
Gastroenterology
Circulating Tumour Necrosis Factor Alpha and Soluble Tumour Necrosis Factor Receptors in Patients With Different Patterns of Rheumatoid Synovitis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics